2-apb (ip3r inhibitor (Millipore)
Structured Review
2 Apb (Ip3r Inhibitor, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ip3r+inhibitor+2-apb/xestospongin+c/10__1016_slash_j__fshw__2023__03__020-35-10-26
Average 90 stars, based on 1 article reviews
Images
Related Articles
Quantitative RT-PCR:Article Title: HSV-1-induced disruption of transcription termination resembles a cellular stress response but selectively increases chromatin accessibility downstream of genes Article Snippet: The Article Title: A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer Article Snippet: Proteasome inhibitor MG132 from Solarbio Life Science (Beijing, China), MEK1/2 inhibitor U0126 and calcium chelating reagent BAPTA from Topscience Co., Ltd (Boston, USA), Infection:Article Title: HSV-1-induced disruption of transcription termination resembles a cellular stress response but selectively increases chromatin accessibility downstream of genes Article Snippet: The Article Title: A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer Article Snippet: Proteasome inhibitor MG132 from Solarbio Life Science (Beijing, China), MEK1/2 inhibitor U0126 and calcium chelating reagent BAPTA from Topscience Co., Ltd (Boston, USA), Cell Culture:Article Title: HSV-1-induced disruption of transcription termination resembles a cellular stress response but selectively increases chromatin accessibility downstream of genes Article Snippet: The Article Title: A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer Article Snippet: Proteasome inhibitor MG132 from Solarbio Life Science (Beijing, China), MEK1/2 inhibitor U0126 and calcium chelating reagent BAPTA from Topscience Co., Ltd (Boston, USA), Expressing:Article Title: HSV-1-induced disruption of transcription termination resembles a cellular stress response but selectively increases chromatin accessibility downstream of genes Article Snippet: The Article Title: A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer Article Snippet: Proteasome inhibitor MG132 from Solarbio Life Science (Beijing, China), MEK1/2 inhibitor U0126 and calcium chelating reagent BAPTA from Topscience Co., Ltd (Boston, USA), Activity Assay:Article Title: HSV-1-induced disruption of transcription termination resembles a cellular stress response but selectively increases chromatin accessibility downstream of genes Article Snippet: The Article Title: A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer Article Snippet: Proteasome inhibitor MG132 from Solarbio Life Science (Beijing, China), MEK1/2 inhibitor U0126 and calcium chelating reagent BAPTA from Topscience Co., Ltd (Boston, USA), Positive Control:Article Title: HSV-1-induced disruption of transcription termination resembles a cellular stress response but selectively increases chromatin accessibility downstream of genes Article Snippet: The Article Title: A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer Article Snippet: Proteasome inhibitor MG132 from Solarbio Life Science (Beijing, China), MEK1/2 inhibitor U0126 and calcium chelating reagent BAPTA from Topscience Co., Ltd (Boston, USA), Dot Blot:Article Title: HSV-1-induced disruption of transcription termination resembles a cellular stress response but selectively increases chromatin accessibility downstream of genes Article Snippet: The Article Title: A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer Article Snippet: Proteasome inhibitor MG132 from Solarbio Life Science (Beijing, China), MEK1/2 inhibitor U0126 and calcium chelating reagent BAPTA from Topscience Co., Ltd (Boston, USA), Inhibition:Article Title: HSV-1-induced disruption of transcription termination resembles a cellular stress response but selectively increases chromatin accessibility downstream of genes Article Snippet: The Article Title: A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer Article Snippet: Proteasome inhibitor MG132 from Solarbio Life Science (Beijing, China), MEK1/2 inhibitor U0126 and calcium chelating reagent BAPTA from Topscience Co., Ltd (Boston, USA), Purification:Article Title: HSV-1-induced disruption of transcription termination resembles a cellular stress response but selectively increases chromatin accessibility downstream of genes Article Snippet: The Article Title: A Novel Mechanism of Endoplasmic Reticulum Stress‐ and c‐Myc‐Degradation‐Mediated Therapeutic Benefits of Antineurokinin‐1 Receptor Drugs in Colorectal Cancer Article Snippet: Proteasome inhibitor MG132 from Solarbio Life Science (Beijing, China), MEK1/2 inhibitor U0126 and calcium chelating reagent BAPTA from Topscience Co., Ltd (Boston, USA), |

